Charles Anthony Laranjeira's Net Worth
$2.15 Million
Who is Charles Anthony Laranjeira?
Charles Anthony Laranjeira has an estimated net worth of $2.15 Million. This is based on reported shares across multiple companies, which include Pacira BioSciences, Inc., and CUBIST PHARMACEUTICALS INC.
SEC CIK
Charles Anthony Laranjeira's CIK is 0001524338
Past Insider Trading and Trends
2013 was Charles Anthony Laranjeira's most active year for acquiring shares with 8 total transactions. Charles Anthony Laranjeira's most active month to acquire stocks was the month of May. 2020 was Charles Anthony Laranjeira's most active year for disposing of shares, totalling 10 transactions. Charles Anthony Laranjeira's most active month to dispose stocks was the month of May. 2020 saw Charles Anthony Laranjeira paying a total of $2,476,837.50 for 107,750 shares, this is the most they've acquired in one year. In 2020 Charles Anthony Laranjeira cashed out on 122,214 shares for a total of $3,192,998.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Pacira BioSciences, Inc. (PCRX) Snapshot price: $28.7125
Chief Technical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.78% | 6K |
$38.35 | $230,100.00 | 41.75K |
Scheduled
|
Jun 14
| ||
Form 4
| +6.40% | 2.15K |
$60.38 | -$467,960.83 | 35.75K |
Scheduled
|
Jun 6 - Jun 8
| ||
Form 4
| +28.73% | 7.5K |
$44.10 | $330,750.00 | 33.6K |
Nov 22
| |||
Form 4
| +37.47% | 7K |
—
|
—
| 25.68K |
Jun 9
| |||
Form 4
| -10.18% | -2.12K |
$61.04 | -$129,215.33 | 18.68K |
Jun 4
| |||
Form 4
|
—
|
0
|
$48.39 | -$21,450.00 | 43.55K |
Scheduled
|
Aug 3
| ||
Form 4
| -15.98% | -3.85K |
$46.17 | -$654,726.91 | 20.25K |
Scheduled
|
Jun 29
| ||
Form 4
| +138.60% | 14K |
—
|
—
| 24.1K |
Jun 9
| |||
Form 4
| -7.87% | -863.00 |
$46.33 | -$39,983.65 | 10.1K |
Jun 4
| |||
Form 4
| +78.83% | 4.57K |
$42.91 | -$18,451.30 | 10.37K |
Jun 4 - Jun 5
| |||
Form 4
| +2,100.84% | 5K |
—
|
—
| 5.24K |
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CUBIST PHARMACEUTICALS INC No price found
SVP, Technical Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$44.00 | -$208,115.00 | 1.26K |
May 20
| |||
Form 4
| +23.61% | 110 |
$46.82 | $5,150.20 | 576 |
Mar 28
| |||
Form 4
| +96.10% | 616 |
$41.40 | -$15,897.72 | 1.26K |
Feb 15 - Feb 19
| |||
Form 4
| +313.55% | 486 |
$33.12 | $16,098.51 | 641 |
Dec 31
| |||
Form 4
| +20.10% | 78 |
$47.69 | $3,719.82 | 466 |
Sep 28
| |||
Form 4
| +87.89% | 254 |
$35.07 | $8,747.73 | 543 |
Jun 29
| |||
Form 4
| +43.07% | 87 |
$43.25 | $3,762.75 | 289 |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +85.32% | 93 |
$39.62 | $3,684.66 | 202 |
Dec 30
| |||
Form 4
|
∞
| 109 |
$35.32 | $3,849.88 | 109 |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||